ESC 365 - Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study

ESC Premium Access

Stroke and all cause mortality with non-vitamin K antagonist oral anticoagulation versus warfarin in atrial fibrillation: a nationwide study

Session: Young Investigators Awards Session Thrombosis

Topic: Atrial fibrillation (AF)

Speaker: Doctor L. Staerk (Hellerup, DK)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Laila Staerk

Gentofte Hospital - Copenhagen University Hospital, Hellerup (Denmark)

0 follower

3 more presentations in this session

PDK1 determines collagen-dependent platelet activation and is critical to development of arterial thrombosis and ischemic stroke in vivo

Speaker: Doctor O. Borst (Tuebingen, DE)

A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial

Speaker: Doctor C. Fanola (Boston, US)

Clinical impact and course of major bleeding events in patients with venous thromboembolism, treated with factor Xa inhibitors or vitamin K antagonists: an individual patient data analysis

Speaker: Ms M. Brekelmans (Amsterdam, NL)

Access the full session

Young Investigators Awards Session Thrombosis

Speakers: Doctor L. Staerk, Doctor O. Borst, Doctor C. Fanola, Ms M. Brekelmans

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources